Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO)

Pamela L. Clemens; Steven Xu; Melody Luo; Ajai Chari; Saad Z. Usmani; Maria-Victoria Mateos; Niels W. C. J. van de Donk; Jonathan L. Kaufman; Philippe Moreau; Albert Oriol; Torben Plesner; Lotfi Benboubker; Jesus F. San-Miguel; X. Yu-Nien Sun; Andrew Farnsworth; Tara Masterson; Peter Hellemans; Ming Qi; Hareth Nahi

doi:10.1182/blood-2018-99-113161

Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO)

Pamela L. Clemens, Steven Xu, Melody Luo, Ajai Chari, Saad Z. Usmani, Maria-Victoria Mateos, Niels W. C. J. van de Donk, Jonathan L. Kaufman, Philippe Moreau, Albert Oriol, Torben Plesner, Lotfi Benboubker, Jesus F. San-Miguel, X. Yu-Nien Sun, Andrew Farnsworth, Tara Masterson, Peter Hellemans, Ming Qi, Hareth Nahi

IRS - Lillebælt Hospital

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	Blood
Volume	132
Issue number	Suppl. 1
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2018-99-113161
Publication status	Published - 29. Nov 2018
Event	60th ASH Annual Meeting - San Diego, United States Duration: 1. Dec 2018 → 4. Dec 2018

Conference

Conference	60th ASH Annual Meeting
Country/Territory	United States
City	San Diego
Period	01/12/2018 → 04/12/2018

Documents & Links

10.1182/blood-2018-99-113161

Cite this

Clemens, P. L., Xu, S., Luo, M., Chari, A., Usmani, S. Z., Mateos, M.-V., van de Donk, N. W. C. J., Kaufman, J. L., Moreau, P., Oriol, A., Plesner, T., Benboubker, L., San-Miguel, J. F., Sun, X. Y.-N., Farnsworth, A., Masterson, T., Hellemans, P., Qi, M., & Nahi, H. (2018). Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO). Blood, 132(Suppl. 1). https://doi.org/10.1182/blood-2018-99-113161

@article{43a293a0a1194df383306b7fb40e298b,

title = "Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO)",

author = "Clemens, {Pamela L.} and Steven Xu and Melody Luo and Ajai Chari and Usmani, {Saad Z.} and Maria-Victoria Mateos and {van de Donk}, {Niels W. C. J.} and Kaufman, {Jonathan L.} and Philippe Moreau and Albert Oriol and Torben Plesner and Lotfi Benboubker and San-Miguel, {Jesus F.} and Sun, {X. Yu-Nien} and Andrew Farnsworth and Tara Masterson and Peter Hellemans and Ming Qi and Hareth Nahi",

year = "2018",

month = nov,

day = "29",

doi = "10.1182/blood-2018-99-113161",

language = "English",

volume = "132",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "Suppl. 1",

note = "60th ASH Annual Meeting ; Conference date: 01-12-2018 Through 04-12-2018",

}

Clemens, PL, Xu, S, Luo, M, Chari, A, Usmani, SZ, Mateos, M-V, van de Donk, NWCJ, Kaufman, JL, Moreau, P, Oriol, A, Plesner, T, Benboubker, L, San-Miguel, JF, Sun, XY-N, Farnsworth, A, Masterson, T, Hellemans, P, Qi, M & Nahi, H 2018, 'Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO)', Blood, vol. 132, no. Suppl. 1. https://doi.org/10.1182/blood-2018-99-113161

Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO). / Clemens, Pamela L.; Xu, Steven; Luo, Melody et al.
In: Blood, Vol. 132, No. Suppl. 1, 29.11.2018.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO)

AU - Clemens, Pamela L.

AU - Xu, Steven

AU - Luo, Melody

AU - Chari, Ajai

AU - Usmani, Saad Z.

AU - Mateos, Maria-Victoria

AU - van de Donk, Niels W. C. J.

AU - Kaufman, Jonathan L.

AU - Moreau, Philippe

AU - Oriol, Albert

AU - Plesner, Torben

AU - Benboubker, Lotfi

AU - San-Miguel, Jesus F.

AU - Sun, X. Yu-Nien

AU - Farnsworth, Andrew

AU - Masterson, Tara

AU - Hellemans, Peter

AU - Qi, Ming

AU - Nahi, Hareth

PY - 2018/11/29

Y1 - 2018/11/29

U2 - 10.1182/blood-2018-99-113161

DO - 10.1182/blood-2018-99-113161

M3 - Journal article

SN - 0006-4971

VL - 132

JO - Blood

JF - Blood

IS - Suppl. 1

T2 - 60th ASH Annual Meeting

Y2 - 1 December 2018 through 4 December 2018

ER -